Document Detail


Dipyridamole stress echocardiography: state of the art 1996. EPIC (Echo Persantin International Cooperative) Study Group.
MedLine Citation:
PMID:  9183606     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Dipyridamole stress is the forerunner and prototype of pharmacological stress echo tests in the diagnosis of coronary artery disease. Among the various stress echo tests, it is probably the least technically demanding to perform and the easiest to interpret. Its accuracy is similar to dobutamine stress echocardiography but its feasibility is higher. The prognostic impact of dipyridamole stress echo has also been proven for presentation of hard end-points such as cardiac death. The safety and prognostic value of this test has been conclusively demonstrated as a result of extensive experience in large scale multicentre projects. Dipyridamole stress is many different tests in one: dipyridamole atropine is best for diagnosis; dipyridamole dobutamine or dipyridamole-exercise is highly sensitive for the detection of minor forms of coronary artery disease; low and high dose dipyridamole is best suited for prognostic stratification; infra-low dipyridamole with low dose dobutamine administration is probably best suited for selective myocardial viability identification. Each patient should have their own test, tailored on the basis of the clinical picture and the diagnostic issue.
Authors:
E Picano; M Ostojic; R Sicari; M Baroni; L Cortigiani; A Pingitore
Related Documents :
12931106 - Enoximone very low-dose dobutamine stress echocardiography: a new test for detecting vi...
1260986 - Influence of dobutamine on regional myocardial blood flow and ventricular performance d...
15068146 - Stress radionuclide myocardial perfusion imaging detects more residual ischemia than st...
11393106 - Comparison of ischemic patterns in myocardial bridge and syndrome x: evaluation by dobu...
9410916 - Myosin heavy chain gene expression in human heart failure.
1798896 - Pet scanning in evaluation of ischemic heart disease.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  European heart journal     Volume:  18 Suppl D     ISSN:  0195-668X     ISO Abbreviation:  Eur. Heart J.     Publication Date:  1997 Jun 
Date Detail:
Created Date:  1997-08-21     Completed Date:  1997-08-21     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  D16-23     Citation Subset:  IM    
Affiliation:
CNR, Institute of Clinical Physiology, Pisa, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Coronary Disease / diagnosis*
Dipyridamole / diagnostic use*
Echocardiography / methods*
Exercise Test / methods*
Humans
Sensitivity and Specificity
Vasodilator Agents / diagnostic use*
Chemical
Reg. No./Substance:
0/Vasodilator Agents; 58-32-2/Dipyridamole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dobutamine stress echocardiography.
Next Document:  Arbutamine stress echocardiography.